The European Association for Haemophilia and Allied Disorders / X
Aug 27, 2026, 13:24
Evolving Perspectives in Haemophilia B Management – EAHAD
European Association for Haemophilia and Allied Disorders shared on LinkedIn:
”Explore the evolving landscape of haemophilia B management, from daily clinical and life challenges to the emerging role of anti-TFPI therapies and their application in real-world scenarios with Jerzy Windyga, Brian O’Mahony and Ana Boban.
Replay the Novo Nordisk symposium on the EAHAD Academy.”
Stay updated with Hemostasis Today.
-
Oct 13, 2026, 11:24Brandon Daniel D’Costa: Building Stronger Stakeholder Relationships Through Empathy and Open Communication
-
Oct 13, 2026, 11:08Renel Tique: 5th International Conference on Hemophilia and Rare Bleeding Disorders
-
Oct 13, 2026, 02:01Nour Al-Mozain: Is It Really Anti-D? – Unraveling Auto-Anti-LW in the Transfusion Laboratory
-
Oct 13, 2026, 01:51Berenice Villegas: The Role of Morphologic Evaluation in Body Fluid Differential Analysis
-
Oct 13, 2026, 01:44Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients
-
Oct 13, 2026, 01:34Nagesh Ramesh: Donating Blood for International Plasma Awareness Week
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF